on april 28, 2011, c&o announced that it has been authorized by shionogi & co., ltd., a japanese pharmaceutical company, to be the exclusive distributor of flumarin®, an antibiotic of oxacephalosporins for injection, in china.
flumarin® (flomoxef sodium for injection) is a broad-spectrum, next-generation oxycephalosporin antibiotic that is effective against a wide range of bacteria, including gram-positive, negative and anaerobic bacteria.